Methotrexate from Japan
Methotrexate is a folic acid antagonist featuring pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. It qualifies for HTS 2934.99.30.00 as an aromatic heterocyclic drug compound used in rheumatoid arthritis and cancer treatments.
Duty Rate — Japan → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit Type II Drug Master Files and bioequivalence data for generic API approval during import clearance
• Provide impurity profiles and chiral purity certificates since it's a single enantiomer drug substance
• Include cytotoxic hazard labeling and UN shipping declarations for safe transport compliance